Literature DB >> 9860353

Primary and secondary prevention of coronary artery disease: trials of lipid lowering with statins.

T A Pearson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9860353     DOI： 10.1016/s0002-9149(98)00806-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

1.  Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9.

Authors:  Nageshwar R Budha; Maya Leabman; Jin Y Jin; D Russell Wada; Amos Baruch; Kun Peng; Whittemore G Tingley; John D Davis
Journal:  AAPS J       Date:  2015-03-31       Impact factor: 4.009

2.  Simvastatin inhibits protein isoprenylation in the brain.

Authors:  Stephen M Ostrowski; Kachael Johnson; Matthew Siefert; Sam Shank; Luigi Sironi; Benjamin Wolozin; Gary E Landreth; Assem G Ziady
Journal:  Neuroscience       Date:  2016-05-12       Impact factor: 3.590

3.  Dyslipidemia.

Authors:  Adam M. Cohen; Daniel J. Rader
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-08

4.  Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS).

Authors:  Yoji Nagai; Tatsuo Kohriyama; Hideki Origasa; Kazuo Minematsu; Chiaki Yokota; Shinichiro Uchiyama; Setsuro Ibayashi; Yasuo Terayama; Makoto Takagi; Kazuo Kitagawa; Eiichi Nomura; Naohisa Hosomi; Toshiho Ohtsuki; Takemori Yamawaki; Yoshihiro Matsubara; Masakazu Nakamura; Yoshimitsu Yamasaki; Etsuro Mori; Masanori Fukushima; Shotai Kobayashi; Yukito Shinohara; Takenori Yamaguchi; Masayasu Matsumoto
Journal:  Int J Stroke       Date:  2013-09-09       Impact factor: 5.266

5.  The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.

Authors:  Naohisa Hosomi; Yoji Nagai; Tatsuo Kohriyama; Toshiho Ohtsuki; Shiro Aoki; Tomohisa Nezu; Hirofumi Maruyama; Norio Sunami; Chiaki Yokota; Kazuo Kitagawa; Yasuo Terayama; Makoto Takagi; Setsuro Ibayashi; Masakazu Nakamura; Hideki Origasa; Masanori Fukushima; Etsuro Mori; Kazuo Minematsu; Shinichiro Uchiyama; Yukito Shinohara; Takenori Yamaguchi; Masayasu Matsumoto
Journal:  EBioMedicine       Date:  2015-08-06       Impact factor: 8.143
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.